Amedisys Inc
NASDAQ:AMED
Amedisys Inc
NASDAQ:AMED
Price:
91.15 USD
-5.06%
Market Closed
Updated:
Jun 1, 2024
Amedisys Inc
Total Equity
|
Amedisys Inc
Total Equity Peer Comparison
Comparables:
DVA
DGX
CVS
CI
LH
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Total Equity
$1.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
DaVita Inc
NYSE:DVA
|
Total Equity
$926m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-15%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Equity
$6.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Equity
$74B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Cigna Corp
NYSE:CI
|
Total Equity
$41.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Equity
$8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
See Also
What is Amedisys Inc's Total Equity?
Total Equity
1.1B
USD
1.1B
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Total Equity amounts to 1.1B USD.
What is Amedisys Inc's Total Equity growth rate?
Total Equity CAGR 10Y
12%
12%
Over the last year, the Total Equity growth was 1%. The average annual Total Equity growth rates for Amedisys Inc have been 11% over the past three years , 16% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
